Neurobell is a neurotechnology company that specializes in developing advanced brain-computer interface (BCI) systems designed to improve the quality of life for individuals with neurological conditions. Their technology focuses on decoding neural signals to enable communication and control for those with paralysis or other impairments.

Neurobell

Neurobell develop novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes.

NeuroBell

We are thrilled to announce that NeuroBell has spun out of UCC and raised €2.1m in seed funding.

The investment round, led by Furthr VC, Atlantic Bridge, HBAN, with participation from Enterprise Ireland and private investors, will allow us to bring our novel technology for seizure detection & EEG monitoring in newborns to market in 2025.

Sincere thanks to University College Cork and INFANT Research Centre for supporting the research and development of the technology, and to the whole NeuroBell team for making this possible.

Mark O'Sullivan Alison O'Shea Colm Murphy
#neurobell #medtech #newborncare 
https://lnkd.in/efPmX92v

Exciting night ahead at Clontarf Castle, Dublin as we are joined by Mark Simpson, our host of the #Seedcorn2023 All-island Final!

Finalists competed in the NI, Dublin, Connacht & Leinster, and Munster regional finals, to walk away with €20,000 each and the chance to compete in tonight’s overall final.

Going head-to-head in our Best New-Start category is Neurodiversity Training International, Brace, Omuu Petfood and Mavarick. While Ilimex Ltd, NeuroBell, Galenband and EVE will compete for the Best Early-Stage title.  

Good luck to all finalists and stay tuned as we announce our overall #Seedcorn2023 winner! 👏

Huge congratulations to Dr. Mark O'Sullivan, INFANT Lead Investigator and co-founder of NeuroBell, who was awarded the "Best Early Stage" Munster regional trophy at the InterTradeIreland Seedcorn Investor Readiness Munster regional final.

The winners were awarded €20,000 and will advance to the All-Island final in Dublin on the 9th of November. The InterTradeIreland Seedcorn Investor Readiness Competition is the largest business competition of its kind on the island of Ireland, Seedcorn has an overall prize fund of €300,000. 

NeuroBell has developed a novel medical device for early detection and monitoring of seizures in newborn infants. Dr. Mark O’Sullivan, Chief Executive of NeuroBell said:

"It is absolutely fantastic to win this award and it will greatly help us in progressing our plans for the business. The prize money will assist our research and development work to make our product globally scalable. As we are in the process of raising Seed Round investment with a view to launching in the US and across Europe, the competition has provided a great opportunity to refine and get feedback on our business plan."

https://lnkd.in/eDwJzF5n

Congratulations to Mavarick and NeuroBell who have won the awards for Best New Start and Best Early Stage, respectively, at our Seedcorn Munster Regional Final.

Leaving with a prize fund of €20,000, these innovative companies are gearing up for the #Seedcorn2023 final on 9th November.

Read more, here https://lnkd.in/edNDj_nS

We’re #hiring a new Embedded Systems Engineer in Cork, County Cork. Apply today or share this post with your network.

#engineering #electronics #firmware #medical #devices #healthcare

Metric
Company Name	Neurobell
Symbol
MSH ID	COM:NEUROBELL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Technology
Country	IE
Stage
Employee Count	5
Website	neurobell.com
LinkedIn	neurobell
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NEUROBELL

Neurobell

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue